Companies / Cognition Therapeutics Inc

Cognition Therapeutics Inc

Nasdaq: CGTXCIK 1455365PURCHASE, NY

Financials

Revenue—
Net income$-23.49M
Total debt—
Cash$34.01M
Diluted EPS$-0.32
Shares outstanding95.1M

Ownership

95.1M shares outstanding · as of Aug 4, 2026
3.4%Insiders
Ownership
Insiders3.44%3,272,591
Institutions23.29%22,146,179
Public float73.27%69,674,976

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Ricciardi LisaCEOCEO & President · Director
1.79%1,706,676
Caggiano AnthonyChief Medical Officer
0.91%864,906
Doyle John BrendanChief Financial Officer
0.65%617,509
Richstone Ellen BDirector
0.09%83,500

Institutional holders 82

View all →
HolderValue% of shares
BIOS Capital Management, LP$8.10M6.31%
Vanguard Group Inc$4.48M3.49%
DAVENPORT & Co LLC$3.88M3.02%
BlackRock, Inc.$1.45M1.33%
Chescapmanager LLC$1.35M1.05%
Renaissance Technologies LLC$848.5K1.17%
Jane Street Group, LLC$829.3K0.65%
Hilton Capital Management, LLC$741.1K0.58%
Geode Capital Management, LLC$699.2K0.97%
Dauntless Investment Group, LLC$629.1K0.49%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 4, 2026Ricciardi Lisa
CEO
OtherCommon Stock$53.3K-52K
-2.93%
1,712,526
1.80% of shares
low
Feb 3, 2026Ricciardi Lisa
CEO
OtherCommon Stock$29.2K-26K
-1.45%
1,764,230
1.86% of shares
low
Feb 4, 2026Doyle John Brendan
Executive
OtherCommon Stock$27.7K-27K
-4.17%
619,069
0.65% of shares
low
Feb 4, 2026Caggiano Anthony
Executive
OtherCommon Stock$27.7K-27K
-3.00%
869,586
0.91% of shares
low
Feb 3, 2026Caggiano Anthony
Executive
OtherCommon Stock$12.9K-11K
-1.27%
896,505
0.94% of shares
low
Feb 15, 2026Ricciardi Lisa
CEO
OtherCommon Stock$6.6K-6K
-0.34%
1,706,676
1.79% of shares
low
Feb 15, 2026Caggiano Anthony
Executive
OtherCommon Stock$5.2K-5K
-0.54%
864,906
0.91% of shares
low
Feb 15, 2026Doyle John Brendan
Executive
OtherCommon Stock$1.7K-2K
-0.25%
617,509
0.65% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CGTXCommon StockEquity19243B102BBG001J2P8S7